How did OPKO Health's revenue and expenses trend in Q4 2024?

OPKO Health's revenue and expenses in Q4 2024 showed a business-oriented revenue structure with diagnostics and pharmaceutical segments contributing significantly. Here's a detailed analysis:

1. **Revenue Trend**:
- The company's total revenue for Q4 2024 was $480.67 million.
- The revenue was distributed across various segments, including diagnostics, pharmaceuticals, services, products, and intellectual property transfers.
- The most significant contributors were the diagnostics segment with $102.84 million and the pharmaceutical segment with $151.95 million.
- The services segment also contributed $102.8 million, while the products and intellectual property transfer segments accounted for $34.8 million and $12.3 million, respectively.
2. **Expense Trend**:
- Total expenses for the period were $183.6 million.
- The company's expense structure did not significantly differ from its revenue segments, indicating a balanced cost allocation.
- The highest expenses were related to the pharmaceutical segment, followed by diagnostics and services.
3. **Net Income**:
- OPKO Health reported a net income of $14 million for Q4 2024.
- This indicates a healthy profitability margin for the period, considering the total revenue and expenses.

In conclusion, OPKO Health demonstrated a robust revenue model with strong contributions from various segments, while managing expenses effectively to achieve a positive net income. This trend suggests a stable financial performance for the company during Q4 2024.

|code|Ticker|Name|Date|Business Composition|Revenue By Business|market_code|
|---|---|---|---|---|---|---|
|OPK|OPK.O|OPKO Health|20240101-2024|Corporate|0|185|
|OPK|OPK.O|OPKO Health|20240101-2024|Corporate|0|185|
|OPK|OPK.O|OPKO Health|20240101-2024|Corporate|0|185|
|OPK|OPK.O|OPKO Health|20240101-2024|Corporate|0|185|
|OPK|OPK.O|OPKO Health|20240101-2024|Corporate|0|185|
|OPK|OPK.O|OPKO Health|20240101-2024|Diagnostics|1.2689E8|185|
|OPK|OPK.O|OPKO Health|20240101-2024|Pharmaceutical|4.6796E7|185|

|code|Ticker|Name|Date|Net Income YoY|Net Income|market_code|
|---|---|---|---|---|---|---|
|OPK|OPK.O|OPKO Health|2024 Q1|-347.99912410357473|-8.1836E7|185|
|OPK|OPK.O|OPKO Health|2024 Q2|47.53054989816701|-1.0305E7|185|
|OPK|OPK.O|OPKO Health|2024 Q3|129.46503616540198|2.489E7|185|
|OPK|OPK.O|OPKO Health|2024 Q4|121.05263157894737|1.4E7|185|

|code|Ticker|Name|Date|Total Revenue YoY|Total Revenue|market_code|
|---|---|---|---|---|---|---|
|OPK|OPK.O|OPKO Health|2024 Q1|-26.89275477003245|1.73686E8|185|
|OPK|OPK.O|OPKO Health|2024 Q2|-31.3588377578009|1.82186E8|185|
|OPK|OPK.O|OPKO Health|2024 Q3|-2.7789131834597836|1.73632E8|185|
|OPK|OPK.O|OPKO Health|2024 Q4|0.9345794392523363|1.836E8|185|